Cisplatin

MYC proto-oncogene, bHLH transcription factor ; Homo sapiens







88 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 22778941 Mechanisms of Cisplatin-Induced Apoptosis and of Cisplatin Sensitivity: Potential of BIN1 to Act as a Potent Predictor of Cisplatin Sensitivity in Gastric Cancer Treatment. 2012 1
52 23225459 Expression analysis of iPS cell - inductive genes in esophageal squamous cell carcinoma by tissue microarray. 2012 Dec 1
53 21324178 c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. 2011 Feb 16 2
54 21447800 c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance. 2011 Mar 29 4
55 20008890 c-MYC depletion potentiates cisplatin-induced apoptosis in head and neck squamous cell carcinoma: involvement of TSP-1 up-regulation. 2010 Mar 1
56 20459793 Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc. 2010 May 11 3
57 20890087 Suppression of Aurora-A oncogenic potential by c-Myc downregulation. 2010 Nov 30 1
58 19054066 Platination of telomeric sequences and nuclease hypersensitive elements of human c-myc and PDGF-A promoters and their ability to form G-quadruplexes. 2009 Jan 1
59 19134217 RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. 2009 Jan 10 1
60 19996588 Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines. 2009 4
61 18375382 c-Myc and caspase-2 are involved in activating Bax during cytotoxic drug-induced apoptosis. 2008 May 23 1
62 17473215 c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells. 2007 May 1 8
63 17628013 Gamma-glutamylcysteine synthetase mediates the c-Myc-dependent response to antineoplastic agents in melanoma cells. 2007 Oct 4
64 16466985 Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin. 2006 Feb 4
65 16681749 Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells. 2006 Mar-Apr 1
66 16788862 Downregulation of the PI3K/Akt survival pathway in cells with deregulated expression of c-Myc. 2006 Aug 1
67 15720258 Cisplatin resistance and transcription factors. 2005 Jan 1
68 16083584 [Adenovirus mediated antisense c-myc gene on the chemotherapy sensitivity of osteosarcoma cells to cisplatin]. 2005 Jun 15 6
69 15153331 Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents. 2004 May-Jun 2
70 12080043 p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression. 2002 Aug 30 1
71 12123658 Quantitation of gene-specific DNA damage by competitive PCR. 2002 Jul 15 1
72 12435808 c-Myc exerts a protective function through ornithine decarboxylase against cellular insults. 2002 Dec 2
73 11408612 c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells. 2001 Jul 7
74 11707650 Modification of the sensitivity to cisplatin with c-myc over-expression or down-regulation in colon cancer cells. 2001 Nov 7
75 10499637 Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin. 1999 Sep 3
76 9443406 c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice. 1998 Jan 15 3
77 9389570 Effects of an inducible anti-sense c-myc gene transfer in a drug-resistant human small-cell-lung-carcinoma cell line. 1997 Nov 14 4
78 8712728 Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines. 1996 Jul-Aug 1
79 8760592 Sensitivity to cis-diamminedichloroplatinum in human cancer cells is related to expression of cyclin D1 but not c-raf-1 protein. 1996 Jul 17 1
80 8862010 Induction of MRP/GS-X pump and cellular resistance to anticancer prostaglandins. 1996 1
81 7827130 Relationships between proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells. 1995 Jan 25 1
82 7923012 Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide. 1994 Nov 1 11
83 7694127 Resistance of human larynx carcinoma cells to cisplatin, gamma-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes. 1993 Nov 1
84 1806037 The effect of cisplatin and carboplatin on c-myc promoter in erythroleukemic cells. 1991 Dec 3
85 1888169 Cis-platin responsive sequences in the human c-myc promoter. 1991 May-Jun 2
86 2009531 Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-myc. 1991 Apr 15 15
87 2064352 Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II). 1991 Mar-Apr 2
88 2113532 Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells. 1990 Jul 5 1